FindTrial
Sign In

Comparison of clinical features and outcomes of RSV-related pneumonia in term and preterm infants

Comparison of clinical features and outcomes of RSV-related pneumonia in term and preterm infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031592
Enrollment
Unknown
Registered
2020-04-05
Start date
2020-04-13
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal RSV-related pneumonia

Interventions

experimental group and control group:None

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. newborns between 7-28 days after birth; 2. Positive for RSV antigen test; 3. Confirmed pneumonia according to the diagnostic criteria formulated by WHO and imaging examination.

Exclusion criteria

Exclusion criteria: Neonates who have received infusion treatment out of hospital, or ventricular septal defect, or cholestasis, or airway dysplasia such as BPD, nostril atresia, airway stenosis, pulmonary hernia, and isolated lung.(excluded if any of these conditions are met)

Design outcomes

Primary

MeasureTime frame
Hospitalization duration;—

Countries

China

Contacts

Public ContactLei Bao

Children's Hospital of Chongqing Medical University

400702@hospital.cqmu.edu.cn+86 18623298567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026